RFK Jr.'s attacks on vaccines go beyond changing the childhood immunization schedule. Now he's taking aim at vaccine R&D ...

Vaccine maker Moderna says the Food and Drug Administration will decide whether to approve its new flu shot for older adults ...

Pfizer reported fourth-quarter revenue and earnings that topped estimates even amid dwindling demand for its Covid products. The pharmaceutical giant reaffirmed the modest 2026 outlook that rattled ...

"Olympics brought us together. This one made us forever." ...

Upstart's (UPST) shares have had a rough couple of months since last summer, diving from over $80 down to the $30 range today. I last covered the company about 1.5 years ago after a positive earnings ...

Americans are living in parallel AI universes. For much of the country, AI has come to mean ChatGPT, Google’s AI overviews, ...

One panelist accused the FDA of withholding data on potential harms. The advisers also are reviewing research on vaccines given to pregnant women.

Smith & Wesson (SWBI) looks undervalued after a cyclical trough—9% normalized FCF yield and 37% upside to $16.06. Read more macro analysis here.

The availability of groceries depends on many things, from import costs to how good last year's harvest was, and a few may become harder to find in 2026.

Moderna has said its new Covid vaccine has been approved and is set to be made in Oxfordshire, a first for this type of vaccine.

Feb 3(Reuters) - Pfizer on Tuesday reported fourth-quarter profit above Wall Street estimates, as sustained demand for older drugs such ‌as blood thinner Eliquis helped offset fading sales of ‌its ...

Moderna reported falling fourth-quarter sales as Covid-19 vaccine demand continued to drop, but continues to target 10% ...